Last reviewed · How we verify

NCT03704727

The Effects of Probiotics on Intestinal Permeability in Gastrointestinal Cancer Patients in Chemotherapy

Completed NA Last updated 18 April 2019
What this trial tests

NA trial testing Probiotic in Intestinal Permeability in 5 participants. Completed in 1 February 2019.

Timeline
1 July 2018
Primary endpoint
1 February 2019
1 February 2019

Quick facts

Lead sponsorUniversity of Copenhagen
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment5
Start date1 July 2018
Primary completion1 February 2019
Estimated completion1 February 2019
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University of Copenhagen

Who can join

18 and older, any sex, with Intestinal Permeability or Gastrointestinal Irritation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to test the hypothesis that adjuvant administration of probiotics in cancer patients undergoing chemotherapy can reduce a chemo-induced increased intestinal permeability. Furthermore, we hypothesize that the use of probiotics may reduce the occurrence of gastrointestinal side effects such as diarrhea, abdominal pains, bacterial translocation and infections following chemotherapy.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Bringing microbiome-drug interaction research into the clinic.
    Guthrie L, Kelly L. · · 2019 · cited 48× · PMID 31151933 · DOI 10.1016/j.ebiom.2019.05.009
  2. Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy.
    Zhu R, Lang T, Yan W, Zhu X, et al · · 2021 · cited 42× · PMID 34026439 · DOI 10.1002/advs.202003542
  3. Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy.
    Singh A, Alexander SG, Martin S. · · 2023 · cited 35× · PMID 37261348 · DOI 10.3389/fimmu.2023.1114499

Verify or expand the search:

Other trials of Probiotic

Trials testing the same drug.

Other recruiting trials for Intestinal Permeability

Currently open trials in the same condition.

Other University of Copenhagen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03704727.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing